Evaluation of drug combinations to sensitize ovarian cancer cells to chemotherapy
Thesis
(2018). Evaluation of drug combinations to sensitize ovarian cancer cells to chemotherapy
Ovarian cancer is a complex disease characterized by low incidence, accounting for about 4% of cancer diagnoses in women, but with rapid progression and higher mortality rate than any other gynecological malignancy. Approximately 70 % of the cases ar... Read More about Evaluation of drug combinations to sensitize ovarian cancer cells to chemotherapy.